P3-323: Ppar-gamma agonist modulates the neuropathic pain and related cognitive deficits: Possible biochemical, mitochondrial evidences

2015 ◽  
Vol 11 (7S_Part_16) ◽  
pp. P762-P762
Author(s):  
Raghavender Pottabathini ◽  
Anil Kumar
Keyword(s):  
Neuropathic Pain ◽  
Cognitive Deficits ◽  
Ppar Gamma ◽  
Ppar Gamma Agonist

scholarly journals Sustained relief of trigeminal neuropathic pain by a blood–brain barrier penetrable PPAR gamma agonist

2019 ◽  
Vol 15 ◽  
pp. 174480691988449 ◽  
Author(s):  
Morgan Zhang ◽  
Min Hu ◽  
Marena A Montera ◽  
Karin N Westlund
Keyword(s):  
Neuropathic Pain ◽  
Blood Brain Barrier ◽  
Ppar Gamma ◽  
Brain Barrier ◽  
Trigeminal Neuropathic Pain ◽  
Blood Brain ◽  
Ppar Gamma Agonist

Effects of a PPAR-gamma agonist, on growth factor and insulin stimulated endothelial cells

2009 ◽  
Vol 51 (2-3) ◽  
pp. 162-168 ◽  
Author(s):  
Cyrus V. Desouza ◽  
Moira Gerety ◽  
Frederick G. Hamel
Keyword(s):  
Endothelial Cells ◽  
Growth Factor ◽  
Ppar Gamma ◽  
Ppar Gamma Agonist

P2-408: A double-blind, placebo-controlled, 18-month pilot study of the PPAR-gamma agonist pioglitazone in Alzheimer's disease

2006 ◽  
Vol 2 ◽  
pp. S366-S366 ◽  
Author(s):  
David S. Geldmacher ◽  
Thomas Fritsch ◽  
McKee J. McClendon ◽  
Alan J. Lerner ◽  
Gary E. Landreth
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Pilot Study ◽  
Ppar Gamma ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Ppar Gamma Agonist
Sign in / Sign up

Export Citation Format

Share Document